| pubmed-article:9128986 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0208804 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C1336708 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0441766 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0021044 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:9128986 | lifeskim:mentions | umls-concept:C1518411 | lld:lifeskim |
| pubmed-article:9128986 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:9128986 | pubmed:dateCreated | 1997-5-22 | lld:pubmed |
| pubmed-article:9128986 | pubmed:abstractText | The clinical Stage I of nonseminomatous germ cell tumors (NSGCT) is inaccurate in 30% of patients. In previous studies on tumor biologic risk factors, low tumor proliferation rates predicted a group of patients at low risk for occult metastatic disease. The goal of this study was to confirm the immunohistochemical assessment of tumor proliferation using MIB-1 (Ki-67 receptor) in a different patient cohort with different investigators to prove the method's reliability. | lld:pubmed |
| pubmed-article:9128986 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9128986 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9128986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9128986 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9128986 | pubmed:month | May | lld:pubmed |
| pubmed-article:9128986 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:AlbersPP | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:OGIKK | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:BierhoffEE | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:FimmersRR | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:WernertNN | lld:pubmed |
| pubmed-article:9128986 | pubmed:author | pubmed-author:MüllerS CSC | lld:pubmed |
| pubmed-article:9128986 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9128986 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9128986 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:9128986 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9128986 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9128986 | pubmed:pagination | 1710-6 | lld:pubmed |
| pubmed-article:9128986 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:meshHeading | pubmed-meshheading:9128986-... | lld:pubmed |
| pubmed-article:9128986 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9128986 | pubmed:articleTitle | MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. | lld:pubmed |
| pubmed-article:9128986 | pubmed:affiliation | Department of Urology, Bonn University Medical Center, Germany. | lld:pubmed |
| pubmed-article:9128986 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9128986 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9128986 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9128986 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9128986 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9128986 | lld:pubmed |
